Dopamine transporter binding in smokers and nonsmokers

Clinical Nuclear Medicine

Volumn 32, Issue 6, 2007, Pages 452-455

  Newberg, Andrew ^a,c   Lerman, Caryn ^a   Wintering, Nancy ^a   Ploessl, Karl ^a   Mozley, P David ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Dopamine transporter; Nicotine; Smoking; SPECT

Indexed keywords

[2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; DOPAMINE TRANSPORTER;

ADULT; ARTICLE; BASAL GANGLION; BINDING KINETICS; BRAIN SCINTISCANNING; CAUDATE NUCLEUS; COMPARATIVE STUDY; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG PROTEIN BINDING; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NEUROIMAGING; PUTAMEN; RETROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMOKING; STATISTICAL SIGNIFICANCE;

ADULT; BRAIN; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; SMOKING; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 34249090172     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000262980.98342.dd     Document Type: Article

References (24)

1. Giros B, Caron M. Molecular characterization of the dopamine transporter. Trends Pharmac Sci. 1993;14:43-49.
2. Jaber M, Jones S, Giros B, et al. The dopamine transporter: a crucial component regulating dopamine transmission. Mov Disord. 1997;12:629-633.
3. Giros B, Jaber M, Jones SR, et al. Hyperlocomotion and indifference to cocaine and methamphetamine in mice lacking the dopamine transporter. Nature. 1996;379:606-612.
4. la Fougere C, Krause J, Krause KH, et al. Value of 99mTc-TRODAT-1 SPECT to predict clinical response to methylphenidate treatment in adults with attention deficit hyperactivity disorder. Nucl Med Commun. 2006;27:733-737.
5. Brunswick DJ, Amsterdam JD, Mozley PD, et al. Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging. Am J Psychiatry. 2003;160:1836-1841.
6. Siderowf A, Newberg A, Chou KL, et al. [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease. Neurology. 2005;64:1716-1720.
7. Allam MF, Campbell MJ, Hofman A, et al. Smoking and Parkinson's disease: systematic review of prospective studies. Mov Disord. 2004;19:614-621.
8. Lerman C, Caporaso N, Main D, et al. Depression and self-medication with nicotine: the modifying influence of the dopamine D4 receptor gene. Health Psychol. 1998;17:56-62.
9. Patterson F, Lerman C, Kaufmann VG, et al. Cigarette smoking practices among American college students: review and future directions. J Am Coll Health. 2004;52:203-210.
10. Krause KH, Dresel SH, Krause J, et al. The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder. Neurosci Biobehav Rev. 2003;27:605-613.
11. Dani JA, Harris RA. Nicotine addiction and comorbidity with alcohol abuse and mental illness. Nat Neurosci. 2005;8:1465-1470.
12. Li S, Kim KY, Kim JH, et al. Chronic nicotine and smoking treatment increases dopamine transporter mRNA expression in the rat midbrain. Neurosci Lett. 2004;363:29-32.
13. Sabol SZ, Nelson ML, Fisher C, et al. A genetic association for cigarette smoking behavior. Health Psychol. 1999;18:7-13.
14. Lerman C, Caporaso NE, Audrain J, et al. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol. 1999;18:14-20.
15. Vandenbergh DJ, Bennett CJ, Grant MD, et al. Smoking status and the human dopamine transporter variable number of tandem repeats (VNTR) polymorphism: failure to replicate and finding that neversmokers may be different. Nicotine Tob Res. 2002;4:333-340.
16. Brody AL, Mandelkern MA, Olmstead RE, et al. Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch Gen Psychiatry. 2006;63:808-816.
17. Drgon T, Lin Z, Wang GJ, et al. Common human 5′ dopamine transporter (SLC6A3) haplotypes yield varying expression levels in vivo. Cell Mol Neurobiol. 2006;26:875-889. Epub ahead of print.
18. Krause KH, Dresel SH, Krause J, et al. Stimulant-like action of nicotine on striatal dopamine transporter in the brain of adults with attention deficit hyperactivity disorder. Int J Neuropsychopharmacol. 2002;5:111-113.
19. Staley JK, Krishnan-Sarin S, Zoghbi S, et al. Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Synapse. 2001;41:275-284.
20. Mozley PD, Acton PD, Barraclough ED, et al. Effects of age on dopamine transporters in healthy humans. J Nucl Med. 1999;40:1812-1817.
21. Mozley PD, Schneider JS, Acton PD, et al. Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers. J Nucl Med. 2000;41:584-589.
22. Kim HJ, Karp JS, Mozley PD, et al. Stimulating technetium-99m cerebral perfusion studies with a three-dimensional Hoffmann brain phantom: collimator and filter selection in SPECT neuroimaging. Ann Nucl Med. 1996;10:153-160.
23. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci. 1978;25:638-643.
24. Li SP, Park MS, Kim JH, et al. Chronic nicotine and smoke treatment modulate dopaminergic activities in ventral tegmental area and nucleus accumbens and the gamma-aminobutyric acid type B receptor expression of the rat prefrontal cortex. J Neurosci Res. 2004;78:868-879.